SCHEMBL3676870

SCHEMBL3676870

O=C(O)Nc1c(Cl)cnc2c1OCO2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACVRL1 P37023 9/20 0.54
BMPR1B O00238 1/20 0.54
BMPR1A P36894 1/20 0.54
ACVR1B P36896 1/20 0.54
TGFBR1 P36897 1/20 0.54
ACVR1 Q04771 1/20 0.54
NPC1 O15118 5/20 0.35
RAB9A P51151 5/20 0.35
TDP1 Q9NUW8 1/20 0.35
MAPT P10636 4/20 0.33
ALDH1A1 P00352 2/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
LMNA P02545 2/20 0.33
HTT P42858 2/20 0.33
HPGD P15428 1/20 0.33
POLB P06746 2/20 0.32
CASP6 P55212 1/20 0.32
CASP3 P42574 2/20 0.31
SENP7 Q9BQF6 2/20 0.31
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3197182 0.80 ACVRL1 (0.47) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL3204033 0.76 ACVRL1 (0.43) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL4029987 0.72 ACVRL1 (0.52) ACVRL1NPC1RAB9APOLBCASP3
SCHEMBL24469661 0.72 ACVRL1 (0.42) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL24469499 0.72 ACVRL1 (0.38) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL30374878 0.69 ATR (0.43) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL21596957 0.69 ATR (0.43) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL3668157 0.69 ACVRL1 (0.39) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL3203728 0.68 ACVRL1 (0.38) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1
SCHEMBL29607098 0.68 ACVRL1 (0.38) ACVRL1BMPR1BBMPR1AACVR1BTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562612-B1 COMBINATION PRODUCT OF INHIBITOR OF THE SRC FAMILY OF NON-RECEPTOR TYROSINE KINASES AND GEMCITABINE FOR USE IN THE TREATMENT OR PROPHLAXIX OF PANCREATIC CANCER ASTRAZENECA AB (SE) 2010-01-27 EP disclosed
EP-1562955-B1 QUINAZOLINE DERIVATIVES AS SRC TYROSINE KINASE INHIBITORS ASTRAZENECA AB (SE) 2008-02-27 EP disclosed